POCARED Diagnostics Ltd, Appoints Mr. Edward J. Ludwig to its Board of Directors

    POCARED Diagnostics Ltd, Appoints Mr. Edward J. Ludwig to its Board of

PR Newswire

REHOVOT, Israel, August 6, 2013

REHOVOT, Israel, August 6, 2013 /PRNewswire/ --

POCARED Diagnostics Ltd, an Israeli-based Diagnostics technology manufacturer,
appoints Mr. Edward J. Ludwig to its Board of Directors.

Mr. Ludwig is former Chairman of the Board, President and Chief Executive
Officer of BD (Becton, Dickinson and Company) (NYSE:BDX), a global medical
technology company headquartered in Franklin Lakes, New Jersey. Mr. Ludwig
joined BD in 1979. He served as CFO from 1995 to 1999. Named President in May
1999 and Chief Executive Officer in January 2000, Mr. Ludwig was elected
Chairman in February 2002. He served as Chief Executive Officer through
September 2011 and Chairman through June 2012. 

"I look forward to joining the POCARED Board and helping the team to achieve
exciting breakthroughs in the rapid accurate diagnosis of infections,"
commented Mr. Ludwig, "Timely, accurate diagnostics are essential to achieving
better healthcare."

"Mr. Ludwig's capabilities and experience are ideal additions to POCARED's™
leadership team as we prepare for our commercialization phase" said Jonathan
Gurfinkel, Founder, President and CEO, POCARED Diagnostics. "On behalf of the
entire Company, I welcome Mr. Ludwig to the POCARED™ family and I look forward
to his contributions to our company's success and growth".

Prior to joining BD, Mr. Ludwig served as a senior auditor with Coopers and
Lybrand (now Pricewaterhouse Coopers), where he earned a CPA certificate, and
as a financial and strategic analyst at Kidde, Inc.

Mr. Ludwig served as a member of the Board of Trustees of the College of the
Holy Cross (2005-2013) and serves on the Columbia Business School Board of
Overseers. He is the Vice Chairman of the Hackensack University Medical
Center Network Board of Trustees.  Mr. Ludwig is a member of the Board of
Directors of Project HOPE, which is dedicated to providing lasting solutions
to health crises, with the mission of helping people to help themselves. In
the corporate arena, Mr. Ludwig serves as Lead Director on Aetna's Board of
Directors and chairs the Board's Finance Committee. He is also a member of the
Board of Directors of Xylem, Inc., a leading global water technology provider
that launched in 2011 from the spinoff of the water-related businesses of ITT

Mr. Ludwig is a Board Member of The Center for Higher Ambition Leadership
which is dedicated to studying, documenting and advancing the principals of
Higher Ambition Leadership which drive the most successful enterprises in
terms of longer term shared value creation. 

Mr. Ludwig is a former Chairman of the Board of Directors of AdvaMed, the
world's largest medical technology association, and a past Chair of the Health
Advisory Board for the Johns Hopkins Bloomberg School of Public Health. Mr.
Ludwig graduated from The College of the Holy Cross with a B.A. in Economics
and Accounting and received his M.B.A. in Finance from Columbia University.

About POCARED Diagnostics

POCARED Diagnostics™ is an in-vitro diagnostics company developing the next
generation microbiology platform. POCARED™ is revolutionizing infectious
disease diagnosis and practice with CULTURE-FREE Microbiology™POCARED's™
P-1000™ platform is fully automated, reagent free, real time and easy to
operate. Providing multi-source, detection, quantification and species
identification results for bacteria and yeast in few minutes, directly from
the specimen, POCARED'™ saves several critical days in result reporting
compared to current practice

For more information about POCARED Diagnostics, please email info@pocared.com

Michal Mendelevich - levy
Tel: +972-8-6999781

SOURCE POCARED Diagnostics Ltd
Press spacebar to pause and continue. Press esc to stop.